bpc-157 clinical trials humans gastrointestinal BPC-157: Miracle Healing Peptide or Hidden Danger? bpc-157 human clinical trials back
Description
Preclinical models show activity over 48 weeks
Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy
If "mitochondrial signaling in aging" is the framing, MOTS-c is the literature favorite
Retrieved 11 February 2026
This isnt a one-size-fits-all treatment
